It has been reported that LY294002 can inhibit the viability of MIA PaCa-2 pancreatic cancer cells to some extent [39], and increase the radiosensitivity of pancreatic cancer cells regardless of their K-ras mutation status [40]. This evidence concerns the gene KRAS and pancreatic neoplasm.